Van Lanschot Kempen Investment Management’s Pfizer PFE Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,173	Closed	-$67K	–	188
2020 Q1	$67K	Hold	2,173	–	–	0.01%	170
2019 Q4	$81K	Sell	2,173 -18,259	-89%	-$650K	0.01%	180
2019 Q3	$697K	Sell	20,432 -4,296	-17%	-$156K	0.06%	135
2019 Q2	$1.02M	Sell	24,728 -8,433	-25%	-$335K	0.09%	125
2019 Q1	$1.34M	Buy	+33,161	New	+$1.33M	0.12%	118
2015 Q4	–	Sell	-867,222	Closed	-$25.8M	–	142
2015 Q3	$25.8M	Sell	867,222 -128,851	-13%	-$4.13M	3.15%	2
2015 Q2	$31.7M	Buy	996,073 +17,865	+2%	+$582K	3.6%	2
2015 Q1	$32.3M	Buy	978,208 +14,756	+2%	+$469K	3.91%	1
2014 Q4	$28.5M	Sell	963,452 -381,864	-28%	-$10.9M	3.13%	13
2014 Q3	$37.7M	Buy	1,345,316 +99,603	+8%	+$2.8M	3.93%	2
2014 Q2	$35.1M	Buy	1,245,713 +98,918	+9%	+$2.82M	3.4%	14
2014 Q1	$34.9M	Sell	1,146,795 -149,932	-12%	-$4.47M	3.32%	15
2013 Q4	$38.4M	Buy	+1,296,727	New	+$37.7M	3.21%	21

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Van Lanschot Kempen Investment Management's PFE Position: Q2 2020 in Review

Van Lanschot Kempen Investment Management sold out of Pfizer (PFE) in Q2 2020, closing a stake of 2,173 shares — an estimated $67K sold.

Van Lanschot Kempen Investment Management first reported a position in PFE in Q4 2013 and held it in 13 quarters. The position peaked at $38.4M in Q4 2013. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Van Lanschot Kempen Investment Management reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
Van Lanschot Kempen Investment Management sold 2,173 Pfizer shares in Q2 2020, an estimated $67K.
Van Lanschot Kempen Investment Management first reported a position in Pfizer in Q4 2013 and held it in 13 quarters.
Van Lanschot Kempen Investment Management's Pfizer position peaked at $38.4M in Q4 2013.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.